Could Trump’s second act boost these ASX psychedelic stocks?
Speculation RFK Jr’s appointment to head US Department of Health and Human Services may favourably impact medical psychedelics sector Tryptamine’s lead asset TRP-8803 is an innovative and scalable psilocin-based IV-infusion…